Drugs that contain Oliceridine

1. List of Olinvyk drug patents

OLINVYK's oppositions filed in EPO
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8835488 TREVENA Opioid receptor ligands and methods of using and making same
Mar, 2032

(8 years from now)

US9309234 TREVENA Opioid receptor ligands and methods of using and making same
Mar, 2032

(8 years from now)

US11077098 TREVENA Opioid receptor ligands and methods of using and making same
Mar, 2032

(8 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9642842 TREVENA Opioid receptor ligands and methods of using and making same
Mar, 2032

(8 years from now)

Do you want to check out OLINVYK patents from before 2022?
Exclusivity Exclusivity Expiration
New Chemical Entity Exclusivity (NCE) Oct 30, 2025

NCE-1 date: 2024-10-30

Market Authorisation Date: 30 October, 2020

Treatment: Management of acute pain by intravenous injection

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage

OLINVYK family patents

11

United States

5

Japan

4

Israel

3

Korea, Republic of

3

European Union

2

Spain

2

Denmark

2

Poland

2

New Zealand

2

Portugal

2

Australia

2

Hungary

1

Hong Kong

1

RS

1

China

1

Brazil

1

Canada

EA

1

EA

1

ME

1

Croatia

1

Cyprus

1

Lithuania

1

Slovenia

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic